"While we’ve achieved universal healthcare coverage; technological, social, and media pressures, as well as the epidemiological transition have put us at risk of being unsustainable in…
In Conversation
"Production capacity, state-of-the-art laboratories, a highly skilled workforce, final consumer orientation, and permanent development are the constituents which have allowed Lekhim to provide the domestic market…
"Indonesia must deliver aggressive growth for our regional business. Anything less than 15 percent would be below our expectations. "
"When companies come to Colombia, they not only envision having a direct operation here, but using Colombia as a platform to grow a regional presence for…
Taiwan’s history with biotech only shows 10 years of focused development. The government is committed to an innovative economy centred around the “5+2 Industrial Innovation Program”…
"We believe in the power of nanotechnology."
"Ukraine itself has had very slow growth in herbal pharmaceuticals and tea sales ... While we progressively achieve our company goals in Ukraine, we will be focusing…
"The strategy has been very clear since the foundation of the company. We are looking for unmet needs in the market that we can fully satisfy…
"Referring to the Swiss heritage, I believe it is very beneficial for the company, as we were trained by Swiss system that taught us how to…
"I think that an original innovation company requires four major ingredients for survival: money, manpower, information, and incentive. For each of those ingredients, I daresay Hong…
"BB-101 is the first new protein drug, with its progression from drug discovery, R&D, preclinical study to clinical trials carried out independently by a domestic biotech…
"The reforms instituted by the government aim to increase coverage, modernize the system and add new medicines to the compulsory plan. This reform represents an opportunity…
